CREXONT
- Product NDC
- 64896-969
- 11-digit product format
- 648960969
- Labeler code
- 64896
- Product ID
- 64896-969_61f8ee81-fe48-4f07-8c6b-aad4701c7f8b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carbidopa and levodopa
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- NDA217186
- Marketing category
- NDA
- Marketing start
- 2024-08-09
- Substance
- CARBIDOPA HYDRATE; LEVODOPA
- Active strength
- 70; 280 mg/1; mg/1
- Pharmacologic classes
- Amino Acids, Aromatic [CS], Aromatic Amino Acid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N217186-001 | CREXONT | CARBIDOPA; LEVODOPA | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | |
| N217186-002 | CREXONT | CARBIDOPA; LEVODOPA | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | |
| N217186-003 | CREXONT | CARBIDOPA; LEVODOPA | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | |
| N217186-004 | CREXONT | CARBIDOPA; LEVODOPA | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N217186-001 | 10098845 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-001 | 10292935 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-001 | 10688058 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-001 | 10973769 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-001 | 10987313 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-001 | 11357733 | 2034-10-07 | Drug product | 2024-08-12 | |
| N217186-001 | 11622941 | 2034-10-07 | Drug product | 2024-08-12 | |
| N217186-001 | 11666538 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-001 | 12064521 | 2034-10-07 | Drug product | 2024-08-21 | |
| N217186-001 | 12128141 | 2034-10-07 | U-219 | Drug product | 2024-11-13 |
| N217186-001 | 12178918 | 2034-10-07 | Drug product | 2025-01-08 | |
| N217186-001 | 12178919 | 2034-10-07 | U-219 | Drug product | 2025-01-08 |
| N217186-001 | 12274793 | 2034-10-07 | Drug product | 2025-05-06 | |
| N217186-001 | 12303605 | 2034-10-07 | Drug product | 2025-06-12 | |
| N217186-001 | 12403099 | 2034-10-07 | Drug product | 2025-09-29 | |
| N217186-001 | 12491164 | 2034-10-07 | Drug product | 2026-01-07 | |
| N217186-001 | 12691074 | 2034-10-07 | Drug product | 2026-07-30 | |
| N217186-001 | 11986449 | 2041-12-21 | U-219 | 2024-08-12 | |
| N217186-001 | 12109185 | 2041-12-21 | U-1649 | 2024-10-11 | |
| N217186-001 | 12109185 | 2041-12-21 | U-219 | 2024-10-11 | |
| N217186-001 | 12109185 | 2041-12-21 | U-4004 | 2024-10-11 | |
| N217186-001 | 12109185 | 2041-12-21 | U-4005 | 2024-10-11 | |
| N217186-001 | 12194150 | 2041-12-21 | U-219 | 2025-01-22 | |
| N217186-001 | 12201596 | 2041-12-21 | U-1649 | 2025-02-05 | |
| N217186-001 | 12201596 | 2041-12-21 | U-4004 | 2025-02-05 | |
| N217186-001 | 12201596 | 2041-12-21 | U-4005 | 2025-02-05 | |
| N217186-001 | 12263148 | 2041-12-21 | U-1649 | 2025-04-17 | |
| N217186-001 | 12263148 | 2041-12-21 | U-219 | 2025-04-17 | |
| N217186-001 | 12263148 | 2041-12-21 | U-4004 | 2025-04-17 | |
| N217186-001 | 12263148 | 2041-12-21 | U-4005 | 2025-04-17 | |
| N217186-001 | 12263149 | 2041-12-21 | U-1649 | 2025-04-17 | |
| N217186-001 | 12263149 | 2041-12-21 | U-219 | 2025-04-17 | |
| N217186-001 | 12263149 | 2041-12-21 | U-4004 | 2025-04-17 | |
| N217186-001 | 12263149 | 2041-12-21 | U-4005 | 2025-04-17 | |
| N217186-001 | 12295931 | 2041-12-21 | U-1649 | 2025-06-12 | |
| N217186-001 | 12295931 | 2041-12-21 | U-219 | 2025-06-12 | |
| N217186-001 | 12295931 | 2041-12-21 | U-4004 | 2025-06-12 | |
| N217186-001 | 12295931 | 2041-12-21 | U-4005 | 2025-06-12 | |
| N217186-001 | 12303481 | 2041-12-21 | U-1649 | 2025-06-20 | |
| N217186-001 | 12303481 | 2041-12-21 | U-219 | 2025-06-20 | |
| N217186-001 | 12303481 | 2041-12-21 | U-4004 | 2025-06-20 | |
| N217186-001 | 12303481 | 2041-12-21 | U-4005 | 2025-06-20 | |
| N217186-001 | 12303482 | 2041-12-21 | U-1649 | 2025-06-12 | |
| N217186-001 | 12303482 | 2041-12-21 | U-219 | 2025-06-12 | |
| N217186-001 | 12303482 | 2041-12-21 | U-4004 | 2025-06-12 | |
| N217186-001 | 12303482 | 2041-12-21 | U-4005 | 2025-06-12 | |
| N217186-001 | 12370163 | 2041-12-21 | U-1649 | 2025-08-25 | |
| N217186-001 | 12370163 | 2041-12-21 | U-219 | 2025-08-25 | |
| N217186-001 | 12370163 | 2041-12-21 | U-4004 | 2025-08-25 | |
| N217186-001 | 12370163 | 2041-12-21 | U-4005 | 2025-08-25 | |
| N217186-001 | 12447139 | 2041-12-21 | U-1649 | 2025-11-13 | |
| N217186-001 | 12447139 | 2041-12-21 | U-219 | 2025-11-13 | |
| N217186-001 | 12447139 | 2041-12-21 | U-4004 | 2025-11-13 | |
| N217186-001 | 12447139 | 2041-12-21 | U-4005 | 2025-11-13 | |
| N217186-001 | 12453710 | 2041-12-21 | U-1649 | 2025-11-13 | |
| N217186-001 | 12453710 | 2041-12-21 | U-219 | 2025-11-13 | |
| N217186-001 | 12453710 | 2041-12-21 | U-4004 | 2025-11-13 | |
| N217186-001 | 12453710 | 2041-12-21 | U-4005 | 2025-11-13 | |
| N217186-001 | 12458616 | 2041-12-21 | U-1649 | 2025-11-18 | |
| N217186-001 | 12458616 | 2041-12-21 | U-219 | 2025-11-18 | |
| N217186-001 | 12458616 | 2041-12-21 | U-4004 | 2025-11-18 | |
| N217186-001 | 12458616 | 2041-12-21 | U-4005 | 2025-11-18 | |
| N217186-002 | 10098845 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-002 | 10292935 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-002 | 10688058 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-002 | 10973769 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-002 | 10987313 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-002 | 11357733 | 2034-10-07 | Drug product | 2024-08-12 | |
| N217186-002 | 11622941 | 2034-10-07 | Drug product | 2024-08-12 | |
| N217186-002 | 11666538 | 2034-10-07 | U-219 | Drug product | 2024-08-12 |
| N217186-002 | 12064521 | 2034-10-07 | Drug product | 2024-08-21 | |
| N217186-002 | 12128141 | 2034-10-07 | U-219 | Drug product | 2024-11-13 |
| N217186-002 | 12178918 | 2034-10-07 | Drug product | 2025-01-08 | |
| N217186-002 | 12178919 | 2034-10-07 | U-219 | Drug product | 2025-01-08 |
| N217186-002 | 12274793 | 2034-10-07 | Drug product | 2025-05-06 | |
| N217186-002 | 12303605 | 2034-10-07 | Drug product | 2025-06-12 | |
| N217186-002 | 12403099 | 2034-10-07 | Drug product | 2025-09-29 | |
| N217186-002 | 12491164 | 2034-10-07 | Drug product | 2026-01-07 | |
| N217186-002 | 12691074 | 2034-10-07 | Drug product | 2026-07-30 | |
| N217186-002 | 11986449 | 2041-12-21 | U-219 | 2024-08-12 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N217186-001 | NP | 2027-08-07 |
| N217186-002 | NP | 2027-08-07 |
| N217186-003 | NP | 2027-08-07 |
| N217186-004 | NP | 2027-08-07 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217186-001 | CREXONT | 35MG;140MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217186-002 | CREXONT | 52.5MG;210MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217186-003 | CREXONT | 70MG;280MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD | 2024-08-07 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217186-004 | CREXONT | 87.5MG;350MG | CAPSULE, EXTENDED RELEASE / ORAL | RLD, RS | 2024-08-07 | 5bbf6a4d5a75… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 10098845 | 2034-10-07 | U-219 | Drug product | 2024-08-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 10292935 | 2034-10-07 | U-219 | Drug product | 2024-08-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 10688058 | 2034-10-07 | U-219 | Drug product | 2024-08-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 10973769 | 2034-10-07 | U-219 | Drug product | 2024-08-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 10987313 | 2034-10-07 | U-219 | Drug product | 2024-08-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 11357733 | 2034-10-07 | Drug product | 2024-08-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 11622941 | 2034-10-07 | Drug product | 2024-08-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 11666538 | 2034-10-07 | U-219 | Drug product | 2024-08-12 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12064521 | 2034-10-07 | Drug product | 2024-08-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12128141 | 2034-10-07 | U-219 | Drug product | 2024-11-13 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12178918 | 2034-10-07 | Drug product | 2025-01-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12178919 | 2034-10-07 | U-219 | Drug product | 2025-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12274793 | 2034-10-07 | Drug product | 2025-05-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12303605 | 2034-10-07 | Drug product | 2025-06-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12403099 | 2034-10-07 | Drug product | 2025-09-29 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12491164 | 2034-10-07 | Drug product | 2026-01-07 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12691074 | 2034-10-07 | Drug product | 2026-07-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 11986449 | 2041-12-21 | U-219 | 2024-08-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12109185 | 2041-12-21 | U-1649 | 2024-10-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12109185 | 2041-12-21 | U-219 | 2024-10-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12109185 | 2041-12-21 | U-4004 | 2024-10-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12109185 | 2041-12-21 | U-4005 | 2024-10-11 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12194150 | 2041-12-21 | U-219 | 2025-01-22 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12201596 | 2041-12-21 | U-1649 | 2025-02-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12201596 | 2041-12-21 | U-4004 | 2025-02-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12201596 | 2041-12-21 | U-4005 | 2025-02-05 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12263148 | 2041-12-21 | U-1649 | 2025-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12263148 | 2041-12-21 | U-4004 | 2025-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12263148 | 2041-12-21 | U-219 | 2025-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12263148 | 2041-12-21 | U-4005 | 2025-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12263149 | 2041-12-21 | U-1649 | 2025-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12263149 | 2041-12-21 | U-219 | 2025-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12263149 | 2041-12-21 | U-4004 | 2025-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12263149 | 2041-12-21 | U-4005 | 2025-04-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12295931 | 2041-12-21 | U-1649 | 2025-06-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12295931 | 2041-12-21 | U-4005 | 2025-06-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12295931 | 2041-12-21 | U-4004 | 2025-06-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12295931 | 2041-12-21 | U-219 | 2025-06-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12303481 | 2041-12-21 | U-1649 | 2025-06-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | 12303481 | 2041-12-21 | U-219 | 2025-06-20 | 84e616aacf4f… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N217186-001 | NP | 2027-08-07 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-002 | NP | 2027-08-07 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-003 | NP | 2027-08-07 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217186-004 | NP | 2027-08-07 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N217186-001 | NP | 2027-08-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217186-002 | NP | 2027-08-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217186-003 | NP | 2027-08-07 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217186-004 | NP | 2027-08-07 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N217186-001 | NP | 2027-08-07 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217186-002 | NP | 2027-08-07 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217186-003 | NP | 2027-08-07 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217186-004 | NP | 2027-08-07 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217186-001 | NP | 2027-08-07 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217186-002 | NP | 2027-08-07 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217186-003 | NP | 2027-08-07 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217186-004 | NP | 2027-08-07 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N217186-001 | NP | 2027-08-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217186-002 | NP | 2027-08-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217186-003 | NP | 2027-08-07 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217186-004 | NP | 2027-08-07 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217186-001 | NP | 2027-08-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217186-002 | NP | 2027-08-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217186-003 | NP | 2027-08-07 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217186-004 | NP | 2027-08-07 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217186-001 | NP | 2027-08-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217186-002 | NP | 2027-08-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217186-003 | NP | 2027-08-07 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217186-004 | NP | 2027-08-07 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217186-001 | NP | 2027-08-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217186-002 | NP | 2027-08-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217186-003 | NP | 2027-08-07 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217186-004 | NP | 2027-08-07 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217186-001 | NP | 2027-08-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217186-002 | NP | 2027-08-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217186-003 | NP | 2027-08-07 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217186-004 | NP | 2027-08-07 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217186-001 | NP | 2027-08-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217186-002 | NP | 2027-08-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217186-003 | NP | 2027-08-07 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217186-004 | NP | 2027-08-07 | 5bbf6a4d5a75… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CREXONT
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CARBIDOPA HYDRATE | 70 mg/1 |
| LEVODOPA | 280 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| MNX7R8C5VO | Internal UNII lookup |
| 46627O600J | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2690259 | Internal RxNorm lookup |
| 2690265 | Internal RxNorm lookup |
| 2690279 | Internal RxNorm lookup |
| 2690281 | Internal RxNorm lookup |
| 2690284 | Internal RxNorm lookup |
| 2690286 | Internal RxNorm lookup |
| 2690290 | Internal RxNorm lookup |
| 2690292 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 095a08b6-b0b8-4f88-b759-67e8b87287a0 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64896-969-16 | CREXONT | 120 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 120 | 18 | |
| 64896-969-16 | CREXONT | 1 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 1 | 18 | |
| 64896-969-23 | CREXONT | 1 in 1 CARTON | CAPSULE, EXTENDED RELEASE | 1 | 18 | |
| 64896-969-23 | CREXONT | 120 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 120 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 64896-969-16 | EA - Each | 64896-969 | c750a259-4722-4313-8163-b36203c0294d | 1 | 2024-09-09 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CREXONT | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 2026-05-29 | Warnings, Adverse reactions | 217186 NDA217186 64896-969 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2690259 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690279 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690284 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690290 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690265 | CREXONT 35 MG / 140 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690281 | CREXONT 52.5 MG / 210 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690286 | CREXONT 70 MG / 280 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690292 | CREXONT 87.5 MG / 350 MG Extended Release Oral Capsule | PSN | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690265 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule [Crexont] | SBD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690281 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule [Crexont] | SBD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690286 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule [Crexont] | SBD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690292 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule [Crexont] | SBD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690259 | carbidopa 35 MG / levodopa 140 MG Extended Release Oral Capsule | SCD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690279 | carbidopa 52.5 MG / levodopa 210 MG Extended Release Oral Capsule | SCD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690284 | carbidopa 70 MG / levodopa 280 MG Extended Release Oral Capsule | SCD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690290 | carbidopa 87.5 MG / levodopa 350 MG Extended Release Oral Capsule | SCD | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690259 | carbidopa 35 MG / L-DOPA 140 MG Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690265 | carbidopa 35 MG / L-DOPA 140 MG Extended Release Oral Capsule [Crexont] | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690279 | carbidopa 52.5 MG / L-DOPA 210 MG Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690281 | carbidopa 52.5 MG / L-DOPA 210 MG Extended Release Oral Capsule [Crexont] | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690284 | carbidopa 70 MG / L-DOPA 280 MG Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690286 | carbidopa 70 MG / L-DOPA 280 MG Extended Release Oral Capsule [Crexont] | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690290 | carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690292 | carbidopa 87.5 MG / L-DOPA 350 MG Extended Release Oral Capsule [Crexont] | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690265 | Crexont (carbidopa 35 MG / levodopa 140 MG) Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690281 | Crexont (carbidopa 52.5 MG / levodopa 210 MG) Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690286 | Crexont (carbidopa 70 MG / levodopa 280 MG) Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
| 2690292 | Crexont (carbidopa 87.5 MG / levodopa 350 MG) Extended Release Oral Capsule | SY | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 19 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 64896-969-16 | 64896096916 | 1 BOTTLE in 1 CARTON (64896-969-16) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2024-08-09 | No | No | Current |
| 64896-969-23 | 64896096923 | 1 BOTTLE in 1 CARTON (64896-969-23) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE | 1 bottle | 2024-08-09 | Yes | No | Current |